Arno Therapeutics, Inc Retained Earnings
Arno Therapeutics, Inc had Retained Earnings of -$103.00 million as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-11-14
- 2016-09-30: Retained Earnings (Accumulated Deficit) -$103.00M.
- 2016-06-30: Retained Earnings (Accumulated Deficit) -$99.15M.
- 2016-03-31: Retained Earnings (Accumulated Deficit) -$97.00M.
- 2015-12-31: Retained Earnings (Accumulated Deficit) -$93.29M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2016-09-30 | -$103.00M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$99.15M 10-Q · filed 2016-08-22 |
| 2016-03-31 | -$97.00M 10-Q · filed 2016-05-16 |
| 2015-12-31 | -$93.29M 10-Q · filed 2016-11-14 |
| 2015-09-30 | -$89.30M 10-Q · filed 2015-11-16 |
| 2015-06-30 | -$88.62M 10-Q · filed 2015-08-14 |
| 2014-12-31 | -$81.79M 10-K · filed 2016-03-30 |
| 2008-06-03 | $120.54K 10-K · filed 2016-03-30 |